1A03440

Abiraterone Ethyl Ether

Pharmaceutical Analytical Impurity (PAI)

• 別名: (3-((3S,8R,9S,10R,13S,14S)-3-ethoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine)
• 実験式（ヒル表記法）: C₂₆H₃₅NO
• CAS番号: 2484719-14-2
• 分子量: 377.56
• MDL number: MFCD18379277
• NACRES: NA.24
• UNSPSC Code: 41116107
• eCl@ss: 25140904

特性

• grade: pharmaceutical analytical impurity (PAI)
• agency: USP
• API family: abiraterone
• manufacturer/tradename: USP
• application(s): pharmaceutical; pharmaceutical; pharmaceutical small molecule
• format: neat
• storage temp.: 2-8°C

詳細

General description

Find answers to frequently asked questions on USP products in USP FAQs.

Abiraterone Ethyl Ether is a USP Pharmaceutical Analytical Impurity (PAI).


USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.


Associated Drug Substance: Abiraterone Acetate


Therapeutic Area: Oncology

Application

Abiraterone Ethyl Ether (USP PAI) is intended for use in analytical testing to detect, identify, and measure pharmaceutical impurities.

Features and Benefits

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:
1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

Other Notes

Sales restrictions may apply.

USP issued SDS can be found here

安全性情報

• ピクトグラム: GHS08,GHS09
• 注意喚起語: Danger
• ハザードコード: H360F,H373,H410
• 注意事項: P202 - P260 - P273 - P280 - P308 + P313 - P391
• Hazard Classifications: Aquatic Chronic 1 - Repr. 1B - STOT RE 2
• 標的臓器: Endocrine system
• 保管分類: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• 一体何が起きているの？: WGK 3
• 引火点 (F): Not applicable
• 引火点（°C）: Not applicable